Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
Min-Sun Kwak, Donghee Kim, Goh Eun Chung, Seung Joo Kang, Min Jung Park, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee
Clin Mol Hepatol. 2012;18(4):383-390.   Published online 2012 Dec 21     DOI: https://doi.org/10.3350/cmh.2012.18.4.383
Citations to this article as recorded by Crossref logo
Serum lactate levels are associated with serum alanine aminotransferase and total bilirubin levels in patients with type 2 diabetes mellitus: A cross-sectional study
Minori Ishitobi, Toshio Hosaka, Naru Morita, Ken Kondo, Toshitaka Murashima, Atsuko Kitahara, Kazuto Takahashi, Yoshikazu Sumitani, Toshiaki Tanaka, Toshihiko Yokoyama, Takuma Kondo, Hitoshi Ishida
Diabetes Research and Clinical Practice.2019; 149: 1.     CrossRef
Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity
Flavia Agata Cimini, Andrea Arena, Ilaria Barchetta, Antonella Tramutola, Valentina Ceccarelli, Chiara Lanzillotta, Mario Fontana, Laura Bertoccini, Frida Leonetti, Danila Capoccia, Gianfranco Silecchia, Claudio Di Cristofano, Caterina Chiappetta, Fabio D
Biochimica et Biophysica Acta (BBA) - Molecular Ba.2019; 1865(6): 1490.     CrossRef
Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia
Ryoichi Fujiwara, Mathias Haag, Elke Schaeffeler, Anne T. Nies, Ulrich M. Zanger, Matthias Schwab
Hepatology.2018; 67(4): 1609.     CrossRef
Bilirubin in the Liver–Gut Signaling Axis
Abdul-Rizaq Hamoud, Lauren Weaver, David E. Stec, Terry D. Hinds
Trends in Endocrinology & Metabolism.2018; 29(3): 140.     CrossRef
Biliverdin reductase and bilirubin in hepatic disease
Lauren Weaver, Abdul-rizaq Hamoud, David E. Stec, Terry D. Hinds
American Journal of Physiology-Gastrointestinal an.2018; 314(6): G668.     CrossRef
Bilirubin, a new therapeutic for kidney transplant?
Vikram L. Sundararaghavan, Sivjot Binepal, David E. Stec, Puneet Sindhwani, Terry D. Hinds
Transplantation Reviews.2018; 32(4): 234.     CrossRef
Loss of biliverdin reductase-A promotes lipid accumulation and lipotoxicity in mouse proximal tubule cells
Samuel O. Adeosun, Darren M. Gordon, Mary Frances Weeks, Kyle H. Moore, John E. Hall, Terry D. Hinds, David E. Stec
American Journal of Physiology-Renal Physiology.2018; 315(2): F323.     CrossRef
Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study
Lei Luo, Ping An, Xinyong Jia, Xiaobian Yue, Sujun Zheng, Shuang Liu, Yu Chen, Wei An, Cheryl A. Winkler, Zhongping Duan
Frontiers in Genetics.2018;[Epub]     CrossRef
Relationship between serum bilirubin concentrations and diabetic nephropathy in Shanghai Han’s patients with type 1 diabetes mellitus
Xu Li, Lei Zhang, Haibing Chen, Kaifeng Guo, Haoyong Yu, Jian Zhou, Ming Li, Qing Li, Lianxi Li, Jun Yin, Fang Liu, Yuqian Bao, Junfeng Han, Weiping Jia
BMC Nephrology.2017;[Epub]     CrossRef
Mice with hyperbilirubinemia due to Gilbert’s syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα
Terry D. Hinds, Peter A. Hosick, Shujuan Chen, Robert H. Tukey, Michael W. Hankins, Andrea Nestor-Kalinoski, David E. Stec
American Journal of Physiology-Endocrinology and M.2017; 312(4): E244.     CrossRef
Does bilirubin protect against developing diabetes mellitus?
Lars H. Breimer, Dimitri P. Mikhailidis
Journal of Diabetes and its Complications.2016; 30(4): 728.     CrossRef
Association between bilirubin and risk of Non-Alcoholic Fatty Liver Disease based on a prospective cohort study
Jianbo Tian, Rong Zhong, Cheng Liu, Yuhan Tang, Jing Gong, Jiang Chang, Jiao Lou, Juntao Ke, Jiaoyuan Li, Yi Zhang, Yang Yang, Ying Zhu, Yajie Gong, Yanyan Xu, Peiyi Liu, Xiao Yu, Lin Xiao, Min Du, Ling Yang, Jing Yuan, Youjie Wang, Weihong Chen, Sheng We
Scientific Reports.2016;[Epub]     CrossRef
Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?
Terry D. Hinds, Samuel O. Adeosun, Abdulhadi A. Alamodi, David E. Stec
Medical Hypotheses.2016; 95: 54.     CrossRef
Bilirubin Binding to PPARα Inhibits Lipid Accumulation
David E. Stec, Kezia John, Christopher J. Trabbic, Amarjit Luniwal, Michael W. Hankins, Justin Baum, Terry D. Hinds, Hervé Guillou
PLOS ONE.2016; 11(4): e0153427.     CrossRef
Total Bilirubin Levels Predict Subclinical Atherosclerosis in Patients With Prediabetes
Hikmet Hamur, Hakan Duman, Levent Demirtas, Eftal Murat Bakirci, Murtaza Emre Durakoglugil, Husnu Degirmenci, Kamuran Kalkan, Erkan Yildirim, Ertan Vuruskan
Angiology.2016; 67(10): 909.     CrossRef
Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α
Terry D. Hinds, Katherine A. Burns, Peter A. Hosick, Lucien McBeth, Andrea Nestor-Kalinoski, Heather A. Drummond, Abdulhadi A. AlAmodi, Michael W. Hankins, John P. Vanden Heuvel, David E. Stec
Journal of Biological Chemistry.2016; 291(48): 25179.     CrossRef
Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance
Min-Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kim, Yoon Jun Kim, Jung-Hwan Yoon
Liver International.2015; 35(3): 944.     CrossRef
Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases
Karl-Heinz Wagner, Marlies Wallner, Christine Mölzer, Silvia Gazzin, Andrew Cameron Bulmer, Claudio Tiribelli, Libor Vitek
Clinical Science.2015; 129(1): 1.     CrossRef
Nonalcoholic Steatohepatitis Associated With Metabolic Syndrome
Kyong Yeun Jung, Sun Young Cho, Hyung Joon Kim, Suk Bae Kim, Il Han Song
Journal of Clinical Gastroenterology.2014; : 1.     CrossRef
Low serum bilirubin concentration is a novel risk factor for the development of albuminuria in patients with type 2 diabetes
Hiroshi Okada, Michiaki Fukui, Muhei Tanaka, Shinobu Matsumoto, Kanae Kobayashi, Hiroya Iwase, Kiichiro Tomiyasu, Koji Nakano, Goji Hasegawa, Naoto Nakamura
Metabolism.2014; 63(3): 409.     CrossRef
The association between indirect bilirubin levels and liver fibrosis due to chronic hepatitis C virus infection
Mustafa Cengiz, Guldal Yılmaz, Seren Ozenirler
Pathology - Research and Practice.2014; 210(8): 488.     CrossRef
Effect of Low Serum Total Bilirubin Levels (≤0.32 mg/dl) on Risk of Coronary Artery Disease in Patients With Metabolic Syndrome
Young Shin Song, Bo Kyung Koo, Nam H. Cho, Min Kyong Moon
The American Journal of Cardiology.2014; 114(11): 1695.     CrossRef
Systematic review: Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?
Mohamed S Anwar
World Journal of Pharmacology.2014; 3(4): 209.     CrossRef
Non-alcoholic fatty liver disease: Factors associated with its presence and onset
Teruki Miyake, Teru Kumagi, Shinya Furukawa, Yoshio Tokumoto, Masashi Hirooka, Masanori Abe, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji
Journal of Gastroenterology and Hepatology.2013; 28: 71.     CrossRef